Javascript must be enabled for the correct page display

An overview: Staphylococcus aureus phage therapy

de Vries, Johan (2019) An overview: Staphylococcus aureus phage therapy. Bachelor's Thesis, Life Science and Technology.


Download (647kB) | Preview
[img] Text
Restricted to Registered users only

Download (233kB)


Staphylococcus aureus (S. aureus) is a common and a frequent virulent pathogen in humans. S. aureus, a ubiquitous bacterium among humans, can cause severe infections such as cellulitis, sepsis and osteomyelitis. The emergence of antibiotics in the 1940s led to believe that bacterial infections would cease to exist. In 1959, however, bacteria started to gain resistance to antibiotics, including S. aureus. Despite the many attempts of developing new antibiotics, bacteria such as Methicillin-resistant Staphylococcus aureus (MRSA) were unaffected. This has led to a renewed interest in phage therapy, a non-antibiotic approach to treat bacterial infections. Here, I will give an overview of the current state of S. aureus phage therapy.

Item Type: Thesis (Bachelor's Thesis)
Supervisor nameSupervisor E mail
Degree programme: Life Science and Technology
Thesis type: Bachelor's Thesis
Language: English
Date Deposited: 12 Aug 2019
Last Modified: 28 Aug 2019 10:08

Actions (login required)

View Item View Item